U.S. GoldMining shares are trading higher after the company announced a positive Preliminary Economic Assessment (PEA) for its Whistler Gold-Copper Project in Alaska.

Allurion Technologies shares are trading lower after receiving a notice from the NYSE about delisting proceedings due to non-compliance with listing standards.

Turning Point Brands shares are trading lower after the company reported an increase in selling, general, and administrative expenses, impacting overall profitability even though net sales boosted due to growth in the Stoker’s segment.

Astrana Health, Inc. shares are trading higher after the company reported impressive fourth quarter and year-end financial results for 2025. The company's total revenue climbed 56% year-over-year to $3,181.8 million, surpassing expectations and hitting the higher end of its guidance range. Adjusted EBITDA also reflected a strong performance, reaching $205.4 million, alongside noteworthy free cash flow. These solid financial metrics point to the effective execution of Astrana's strategic initiatives and robust growth prospects for the future.

ADT shares are trading lower despite the company reporting strong financial results for 2025 and announcing a new $1.5 billion share repurchase authorization. The decline comes as income from continuing operations dipped by $51 million in the fourth quarter compared to the previous year.

Pulmatrix shares are trading lower after the company announced the termination of its planned merger agreement with Cullgen due to delays in regulatory approvals.

Rallybio shares are trading higher after announcing a definitive agreement to acquire Candid Therapeutics through a merger transaction, bolstered by an oversubscribed financing round of over $505 million.

BioAtla shares are trading lower after the company announced a formal process to evaluate strategic options to monetize assets and a significant 70% workforce reduction as part of a restructuring plan.

Sabre Corporation shares are trading higher after the company adopted a limited-duration shareholder rights plan, responding to substantial stock accumulation by Constellation Software.

nLIGHT, Inc. (NASDAQ: LASR) shares are trading higher after the company announced it will showcase its advanced high-energy laser weapon solutions at the Pacific Operational Science & Technology Conference.

AES shares are trading lower after the announcement of its acquisition by a consortium led by Global Infrastructure Partners and EQT, which will take the company private, leading to its stock being delisted from the New York Stock Exchange upon the transaction's completion.

AMTD Digital shares are trading higher after the company reported a 565.7% increase in revenue, a 132.7% increase in net income, and a 280.2% increase in net assets for the fiscal year ended October 31, 2025.

BWIN shares are trading higher after the company reported an 8% increase in total revenue to $1.5 billion and a 7% organic revenue growth year-over-year, highlighting its strong market performance despite headwinds.

Relay Therapeutics shares are trading higher after the company reported promising clinical advancements with its lead program, zovegalisib, which received Breakthrough Therapy designation from the FDA.

Puma Biotechnology shares are trading lower after the company reported a decline in Q4 net income compared to the previous year, impacted by changes in valuation allowances.

Progyny shares are trading lower after a large client did not renew its services agreement for 2025, impacting fourth-quarter revenue figures.

Sunrun shares are trading lower after the company reported a 17% decrease in subscriber additions and an 18% drop in aggregate subscriber value for Q4 2025, despite a significant increase in total revenue.

PAR Technology shares are trading lower after the company reported financial results for Q4 2025, showing continued net losses despite revenue growth. Key concerns include a decline in subscription service gross margin percentage and ongoing losses from continuing operations.

Biodesix shares are trading higher after the company reported a 41% revenue growth and achieved its first-ever Adjusted EBITDA positivity in Q4 2025, with FY2026 revenue guidance reflecting a 23% growth.

FIGS, Inc. shares are trading higher after the company reported a 33% year-over-year increase in Q4 net revenues coupled with improving profitability and strong demand momentum.